Invites Healthcare Co., Ltd. agreed to acquire Invites Genomics Co., Ltd. from Invites Biocore Co., Ltd. (XKON:A216400) for KRW 10 billion on May 17, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8,750 KRW | +0.34% | -7.31% | -5.91% |
1st Jan change | Capi. | |
---|---|---|
-5.91% | 49.5M | |
-27.66% | 9.88B | |
+26.94% | 2.89B | |
-15.73% | 2.12B | |
-20.83% | 1.67B | |
+67.18% | 1.45B | |
+26.08% | 788M | |
-4.15% | 741M | |
-28.78% | 514M | |
+3.98% | 308M |
- Stock Market
- Equities
- A216400 Stock
- News Invites Biocore Co., Ltd.
- Invites Healthcare Co., Ltd. agreed to acquire Invites Genomics Co., Ltd. from Invites Biocore Co., Ltd. for KRW 10 billion